Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
[Prevalence of multiple sclerosis in the Region of Murcia].
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Clinically isolated syndromes.
Effects of dimethyl fumarate on lymphocyte subsets.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need.
CombiRx for MS not better than monotherapy
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Management of women with multiple sclerosis through pregnancy and after childbirth.
Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Understanding the Role of T Cells in CNS Homeostasis.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.

Pages